# China NMPA Drug Inspection - Hsin-Tung Biotechnology Co., Ltd. - Sodium valproate sustained-release tablets

Source: https://www.globalkeysolutions.net/records/china_drug_inspection/hsin-tung-biotechnology-co-ltd/3aaaec2d-5120-4e7a-a8ff-5bc8891a12a3/
Source feed: China

> China NMPA drug inspection for Hsin-Tung Biotechnology Co., Ltd. published June 17, 2021. Drug: Sodium valproate sustained-release tablets. 

---

## Details

- Record Type: CHINA_DRUG_INSPECTION
- Title: Guangdong Provincial Drug Administration's Announcement Regarding Drug Sampling and Inspection Information (Issue 4, 2021)
- Company Name: Hsin-Tung Biotechnology Co., Ltd.
- Publication Date: 2021-06-17
- Drug Name: Sodium valproate sustained-release tablets
- Inspection Finding: Meets the requirements of drug standards (qualified)
- Action Taken: It does not involve the investigation and handling of substandard drugs.

Company: https://www.globalkeysolutions.net/companies/hsin-tung-biotechnology-co-ltd/f0eb8e11-cc73-43ac-9d83-56fb755f0c61/